Reshaping the HIV treatment and prevention landscape
Cash and working capital
Cash generated from operations
£10.1bn
Group
2020
More than £10bn
New GSK
2020
New GSK
2026
Cash generated from operations is Net Cash Flow inflow from operating activities before tax paid
DSO Days Sales Outstanding; DPO Days Payables Outstanding; RAR Returns and Rebates; DIO Days Inventory Outstanding;
gsk
Strengthen cash generation and conversion:
Revenue growth
Margin expansion
Working capital management
Restructuring and separation programmes complete
Working capital and cash management:
-
-
Top quartile performance in DSO, DPO and RAR
Increase focus on DIO, significant but long cycle opportunity
Corp treasury delivering top quartile cash management,
funding strategy and cost of funds
Target short-term credit ratings of A-1/P-1
and commensurate long term-ratings
107View entire presentation